Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting

References

• LauerGMWalkerBDHepatitis C virus infectionN Engl J Med20013451415211439948
   PubMed Web of Science ®Google Scholar
• SeeffLBThe history of the “natural history” of hepatitis C (1968–2009)Liver Int200929Suppl 18999
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)2002 Hepatitis C Available from: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/Accessed November 18, 2014
   Google Scholar
• ChenSLMorganTRThe natural history of hepatitis C virus (HCV) infectionInt J Med Sci200632475216614742
   PubMedGoogle Scholar
• WasleyAAlterMJEpidemiology of hepatitis C: geographic differences and temporal trendsSemin Liver Dis2000201116
   PubMed Web of Science ®Google Scholar
• CharltonMHepatitis C infection in liver transplantationAm J Transplant20011319720312102252
   PubMed Web of Science ®Google Scholar
• LavanchyDEvolving epidemiology of hepatitis C virusClin Microbiol Infect201117210711521091831
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGuidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection2014 Available from: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/Accessed June 28, 2016
   Google Scholar
• StrazzullaACostaCPisaniVPresent, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antiviralsBMC Infect Dis201414Suppl 5S3
   Web of Science ®Google Scholar
• NegroFEpidemiology of hepatitis C in EuropeDig Liver Dis201446Suppl 5S158S16425453870
   PubMedGoogle Scholar
• Mohd HanafiahKGroegerJFlaxmanADWiersmaSTGlobal epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalenceHepatology20135741333134223172780
   PubMed Web of Science ®Google Scholar
• SEIEVA Collaborative GroupEpidemiology of acute viral hepatitis in Italy: results of the surveillance through SEIEVAAnnual Report Rome2015 Available from: http://www.iss.it/seieva/index.php?lang=1&anno=2016&tipo=5Accessed August 24, 2016
   Google Scholar
• Deuffic-BurbanSCastelHWiegandJMannsMPWedemeyerHMathurinPYazdanpanahYImmediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysisJ Hepatol201257226026622521356
   PubMed Web of Science ®Google Scholar
• HolmbergSDSpradlingPRMoormanACDennistonMMHepatitis C in the United StatesN Engl J Med2013368201859186123675657
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL recommendations on treatment of hepatitis C 2014J Hepatol201461237339524818984
   PubMed Web of Science ®Google Scholar
• MenniniFSMarcellusiAAndreoniMGasbarriniASalomoneSCraxiAHealth policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in ItalyClinicoecon Outcomes Res2014630331024971024
   PubMedGoogle Scholar
• AIFA Guideline for the Classification and Conduction of the Observational Studies on Medicines Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdfAccessed June 28, 2016
   Google Scholar
• MannsMPvon HahnTNovel therapies for hepatitis C – one pill fits all?Nat Rev Drug Discov201312859561023807378
   PubMed Web of Science ®Google Scholar
• Epidemiologia, sorveglianza e promozionde della salute (SEIEVA)Istituto Superiore di Sanità (ISS) [National Center for Epidemiology, Surveillance and Health Promotion SEIEVA Collaborative Group (Italian National Institute of Health)] Available from: http://www.iss.it/seieva/index.php?lang=1&anno=2014&tipo=4. Last update: November 28, 2014
   Google Scholar
• MarascioNLibertoMBarrecaGUpdate on epidemiology of HCV in Italy: focus on the Calabria RegionBMC Infect Dis201414Suppl 5S2
   Web of Science ®Google Scholar
• MarcellinPHepatitis C: the clinical spectrum of the diseaseJ Hepatol199931Suppl 191610622554
   PubMed Web of Science ®Google Scholar
• ChopraSDi BisceglieAMBloomAUpToDate. Hepatitis C2016 Available from: http://www.uptodate.com/contents/hepatitis-c-beyond-the-basicsAccessed June 28, 2016
   Google Scholar
• AscioneATartaglioneTDi CostanzoGGNatural history of chronic hepatitis C virus infectionDig Liver Dis200739Suppl 1S4S717936222
   PubMedGoogle Scholar
• CorraoGAricoSIndependent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosisHepatology19982749149199537428
   PubMed Web of Science ®Google Scholar
• StroffoliniTSpadaroAGuadagninoVCurrent practice of hepatitis C treatment in Southern ItalyDig Liver Dis2010421182282520435532
   PubMedGoogle Scholar
• McGowanCEMonisABaconBRA global view of hepatitis C: physician knowledge, opinions, and perceived barriers to careHepatology20135741325133223315914
   PubMed Web of Science ®Google Scholar
• PereiraKMirandaACBaptistaTAnalysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patientsJ Int AIDS Soc2014174 Suppl 31964525394149
   PubMed Web of Science ®Google Scholar
• MorrillJAShresthaMGrantRWBarriers to the treatment of hepatitis C. Patient, provider, and system factorsJ Gen Intern Med200520875475816050887
   PubMed Web of Science ®Google Scholar
• CrespoJCabezasJSacristanBBarriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practiceLiver Int201535240140824650000
   PubMed Web of Science ®Google Scholar
• BiniEJBrauNCurrieSProspective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionAm J Gastroenterol200510081772177916086714
   PubMed Web of Science ®Google Scholar
• McAdam-MarxCMcGarryLJHaneCABiskupiakJDenizBBrixnerDIAll-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspectiveJ Manag Care Pharm201117753154621870894
   PubMed Web of Science ®Google Scholar
• GordonSCPockrosPJTerraultNAHoopRSBuikemaANerenzDHamzehFMImpact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infectionHepatology20125651651166022610658
   PubMed Web of Science ®Google Scholar
• GordonSCHamzehFMPockrosPJHoopRSBuikemaARKornerEJTerraultNAHepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver diseaseAliment Pharmacol Ther201338778479323981040
   PubMed Web of Science ®Google Scholar